Alkindi Pharmaceutical Industries Company
15-Sep-2013
On September 10.2013 Jordan Securities Commission (JSC) Board of Commissioners decided to address the Securities Depository Center (SDC) on each of the following:
1. Allow to transfer ownership of shares registered at the (SDC) among the current shareholders of Alkindi Pharmaceutical Industries Company. The transfer process shall take place exclusively via the (SDC) and in accordance with legislations in force.
2. Cancel the stated shareholders shares in the decision of the Extraordinary General Meeting held on August 5.2013, at a total number of (617.966) shares and on the accountability of relevant parties.
3. Ensure that the company includes in its paid-up capital disclosure stated in its financial statements, the Board of Commissioners decision No. (382/2008) dated July 22.2013. It contains the Boards’ disapproval of the company’s request to register capital increase in shares of (5.266.087) million shares by capitalizing Kuwait Finance House/Bahrain-debts.
4. Disclose the letter of the company’s Legal Advisor.